Imagine a steel vat filled with healthy, organic yeast creating THC, CBDs and other cannabinoids as their waste byproduct, which is harvested for both medical and recreational use.
This is now, not the future. Cannabis entrepreneurs have suddenly been flooded with tons of investment money and are using scientific research to find new ways of increasing production yields, improving quality, and to continue providing cannabis-based products to the ever-expanding marketplace.
The push is on to satisfy the millions of users in newly legal states in the USA, and around the world. In recent years the use of CBDs for medical… Continue reading
Tubingen, Germany: The administration of FDA-approved synthetic THC (dronabinol) induces death in leukemia cell lines and offers a “low-toxic therapy option” for patients with cancer, according to findings published online in the journal BMC Cancer.
German researchers evaluated the impact of dronabinol on leukemia cells. Investigators reported that synthetic THC displayed “remarkable anti-proliferative as well as pro-apoptopic efficacy … in a broad spectrum of acute leukemia cell lines.” These findings “provide a promising rationale for the clinical use of cannabinoids … in distinct entities of acute leukemia,” they concluded.
Preclinical data dating back over four decades has consistently documented the… Continue reading